Elmiron (pentosan polysulfate sodium), a drug widely prescribed for a bladder condition, has been associated with eye damage. Hundreds of thousands of people who have taken Elmiron may have been exposed to the risk of potentially permanent vision damage. Recent studies suggest that Elmiron is toxic to the retina, and one study shows that about 25 percent of patients with significant exposure to the drug show signs of retinal damage. As a result of these studies, vision loss lawsuits have been filed against Janssen Pharmaceuticals for failing to properly warn the public about the risk of vision problems.
Settlement: oalition of 24 State Attorneys General Announces over $550 Million Settlements with Nation’s Largest Subprime Autho Financing Company
June 24, 2020